期刊文献+

临床护理路径对肾小球肾炎患者临床疗效及心理特点影响分析

Effect of Clinical Nursing Pathway on Clinical Curative Effect and Psychological Characteristics of Patients with Glomerulonephritis
下载PDF
导出
摘要 目的分析临床护理路径对肾小球肾炎患者临床疗效及心理特点影响。方法选取肾小球肾炎患者160例,将患者按护理路径的不同分为对照组(80例)和观察组(80例),对照组患者应用常规护理路径,观察组增加临床护理路径,比较两组的临床疗效、治疗前后的血压控制情况、平均每日睡眠时间及心理特点进行对比。结果观察组患者的睡眠时间、焦虑抑郁评分、血压与治疗情况与对照组相比差异显著(P<0.05)。结论对肾小球肾炎患者应用临床护理路径,有效控制患者的血压,也有助于患者恢复。 Objective to analyze the clinical effect and psychological characteristics of patients with glomerulonephritis.Methods 160 cases of glomerulonephritis were selected,and the patients were divided into control group (80 cases)and observation group (80 cases)according to different nursing paths.In the control group,routine nursing paths were applied and clinical nursing paths were added in the observation group.The clinical efficacy, blood pressure control before and after treatment,average daily sleep time and psychological characteristics of the two groups were compared.Results there were significant differences in sleep duration,anxiety and depression scores,blood pressure and treatment between the observation group and the control group (P<0.05).Conclusion the application of clinical nursing pathway in patients with glomerulonephritis can effectively control the blood pressure of the patients and also help the patients to recover.
作者 佟海青 谷桂芳 TONG Hai-qing;GU Gui-fang(Shandong University Qilu Hospital,Jinan,Shandong,266000)
出处 《智慧健康》 2018年第30期24-25,共2页 Smart Healthcare
关键词 临床护理路径 肾小球肾炎患者 心理特点 Clinical nursing path Patients with glomerulonephritis Psychological characteristics
  • 相关文献

参考文献7

二级参考文献56

  • 1傅艳霞.慢性肾小球肾炎患者健康教育采用临床护理的价值分析[J].医学信息(医学与计算机应用),2014,0(23):554-554. 被引量:5
  • 2余宝莲,武芳慧.实施临床路径的影响因素分析[J].护理研究,2004,18(12):2143-2143. 被引量:21
  • 3刘宝厚,许筠.慢性肾小球肾炎的诊断、辨证分型及疗效评定(试行方案)[J].上海中医药杂志,2006,40(6):8-9. 被引量:400
  • 4胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 5KChuang SY, Chen JH, Yeh WT, et al. Hyperuricemia and in- creased risk of ischemic heart disease in a large Chinese cohort [ J]. International Journal of Cardiology, 2012,154 ( 3 ) : 316- 321.
  • 6Harzand A, Tamariz L, Hare JM, et al. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition [J ]. Congest Heart Fail ,2012,5 ( 3 ) : 178-182.
  • 7Inzucchi SE, Zinman B, Wanner C. SGLT-2 inhibitors and car- diovascular risk: Proposed pathways and review of ongoing outcome trials [ J ]. Diabetes & Vascular Diseases Research, 2015,12(2) :90-100.
  • 8Dousdampanis P, Trigka K, Musso CG. Hyperuricemia and chronic kidney disease:an enigma yet to be solved [ J ]. Ren Fail,2014,36 (9) : 1351-1359.
  • 9Ritz E, Schmieder RE, Pollock CA. Renal protection in diabe- tes:lessons from ONTARGET [ J]. Cardiovasc Diabetol,2010, 9:60.
  • 10Smink PA, Bakker S J, Laverman GD, et al. An initial reduction in serum uric acid during Angiotensin receptor blocker treat- ment is associated with cardiovascular protection: a post-hoc a- naiysis of the RENAAL andI DN Ttrials [J]. J Hypertens, 2012,30 (5) : 1022-1028.

共引文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部